Barclays PLC Staar Surgical CO Transaction History

Barclays PLC

$377 Billion
Q3 2024

A detailed history of Barclays PLC transactions in Staar Surgical CO stock. As of the latest transaction made, Barclays PLC holds 91,707 shares of STAA stock, worth $2.45 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

91,707

Previous 91,707 -0.0%

Holding current value

$2.45 Million

Previous $3.41 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 15, 2024	BUY	$29.97 - $47.42 $2.14 Million - $3.38 Million	71,301 Added 349.41%	91,707 $3.41 Million
Q2 2024 Aug 14, 2024	SELL	$38.07 - $52.25 $995,454 - $1.37 Million	-26,148 Reduced 56.17%	20,406 $973,000
Q1 2024 May 15, 2024	SELL	$27.67 - $39.61 $1.05 Million - $1.51 Million	-38,101 Reduced 45.01%	46,554 $1.78 Million
Q4 2023 Feb 15, 2024	BUY	$30.6 - $43.78 $221,146 - $316,398	7,227 Added 9.33%	84,655 $2.64 Million
Q3 2023 Nov 07, 2023	BUY	$39.39 - $58.12 $174,340 - $257,239	4,426 Added 6.06%	77,428 $3.11 Million
Q2 2023 Aug 03, 2023	SELL	$50.45 - $72.82 $3.41 Million - $4.92 Million	-67,499 Reduced 48.04%	73,002 $3.84 Million
Q1 2023 May 04, 2023	BUY	$51.25 - $79.34 $1.76 Million - $2.73 Million	34,400 Added 32.42%	140,501 $8.98 Million
Q4 2022 Feb 13, 2023	BUY	$46.82 - $76.2 $3.93 Million - $6.39 Million	83,894 Added 377.78%	106,101 $5.15 Million
Q3 2022 Nov 03, 2022	BUY	$70.55 - $111.58 $510,358 - $807,169	7,234 Added 48.31%	22,207 $1.57 Million
Q2 2022 Aug 12, 2022	BUY	$50.24 - $80.48 $273,205 - $437,650	5,438 Added 57.03%	14,973 $1.06 Million
Q1 2022 May 16, 2022	SELL	$57.98 - $93.5 $13.7 Million - $22 Million	-235,797 Reduced 96.11%	9,535 $762,000
Q4 2021 Feb 14, 2022	BUY	$88.02 - $127.79 $14.9 Million - $21.7 Million	169,682 Added 224.3%	245,332 $22.4 Million
Q3 2021 Nov 09, 2021	BUY	$122.75 - $162.68 $2.19 Million - $2.9 Million	17,808 Added 30.79%	75,650 $9.72 Million
Q2 2021 Aug 13, 2021	BUY	$105.76 - $154.96 $231,402 - $339,052	2,188 Added 3.93%	57,842 $8.82 Million
Q1 2021 May 13, 2021	BUY	$78.5 - $126.48 $1.45 Million - $2.33 Million	18,431 Added 49.52%	55,654 $5.87 Million
Q4 2020 Feb 11, 2021	SELL	$55.93 - $82.78 $1.06 Million - $1.58 Million	-19,030 Reduced 33.83%	37,223 $2.95 Million
Q3 2020 Nov 12, 2020	SELL	$45.65 - $61.81 $851,829 - $1.15 Million	-18,660 Reduced 24.91%	56,253 $3.18 Million
Q2 2020 Aug 12, 2020	BUY	$29.15 - $61.54 $1.75 Million - $3.69 Million	59,937 Added 400.22%	74,913 $4.61 Million
Q1 2020 May 13, 2020	SELL	$25.01 - $42.4 $742,947 - $1.26 Million	-29,706 Reduced 66.48%	14,976 $483,000
Q4 2019 Feb 10, 2020	SELL	$24.55 - $38.13 $1.5 Million - $2.33 Million	-61,165 Reduced 57.79%	44,682 $1.57 Million
Q3 2019 Nov 14, 2019	BUY	$25.78 - $34.8 $290,153 - $391,673	11,255 Added 11.9%	105,847 $2.73 Million
Q2 2019 Aug 14, 2019	BUY	$23.08 - $37.01 $1.31 Million - $2.09 Million	56,599 Added 148.97%	94,592 $2.78 Million
Q1 2019 May 15, 2019	BUY	$27.81 - $40.78 $378,855 - $555,545	13,623 Added 55.9%	37,993 $1.3 Million
Q4 2018 Feb 14, 2019	BUY	$28.91 - $50.0 $37,004 - $64,000	1,280 Added 5.54%	24,370 $778,000
Q3 2018 Nov 14, 2018	SELL	$30.85 - $50.65 $318,156 - $522,353	-10,313 Reduced 30.87%	23,090 $1.11 Million
Q2 2018 Aug 14, 2018	BUY	$13.95 - $32.65 $274,759 - $643,074	19,696 Added 143.69%	33,403 $1.04 Million
Q1 2018 May 15, 2018	SELL	$14.35 - $16.5 $71,290 - $81,972	-4,968 Reduced 26.6%	13,707 $202,000
Q4 2017 Feb 14, 2018	BUY	$12.45 - $17.4 $218,783 - $305,770	17,573 Added 1594.65%	18,675 $291,000
Q3 2017 Nov 14, 2017	BUY	$10.25 - $12.8 $11,295 - $14,105	1,102	1,102 $14,000

Others Institutions Holding STAA

# of Institutions

255

Shares Held

47.8M

Call Options Held

427K

Put Options Held

206K

View Full List

About STAAR SURGICAL CO

Ticker STAA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 48,038,300
Market Cap $1.28B
Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...

More about STAA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account